4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-016983
Options or other derivatives
- Executive Vice President & CFO acquired 434,364 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2021-03-01 | Grant or award · Restricted Stock Units | +144,788 | 144,788 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2021-03-01 | Grant or award · Performance-Based Restricted Stock Units | +289,576 | 289,576 | D | ||
Loading xslF345X03/doc4.xml…